CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on improving the solubility of poorly soluble active pharmaceutical ingredients (APIs) by developing a dynamic physio-chemical method to understand phase transformations in amorphous drugs. The goal is to enhance the bioavailability of these drugs through innovative techniques in crystal nucleation…
One of the most important challenges that drug development researchers face today is the low aqueous solubility of the active pharmaceutical ingredients (APIs).
Most of the drug molecules under investigation exhibit poor water solubility and additional efforts are required to improve their solubility feature.
Thus, the development of amorphous drugs is the most effective way how to improve the bioavailability of the APIs, and huge amount of effort is directed towards this smart approach.
The aim…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 topics.
Guests see up to 5 keywords.
